首页> 美国卫生研究院文献>Clinical and Diagnostic Laboratory Immunology >Immunochromatographic Test for Simultaneous Serodiagnosis of Babesia caballi and B. equi Infections in Horses
【2h】

Immunochromatographic Test for Simultaneous Serodiagnosis of Babesia caballi and B. equi Infections in Horses

机译:免疫色谱法同时对马的巴贝斯球菌和马来酸杆菌感染进行血清学诊断

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

An immunochromatographic test for the simultaneous detection of Babesia caballi- and B. equi-specific antibodies (BceICT) was developed using a recombinant B. caballi 48-kDa rhoptry protein (rBc48) and a recombinant truncated B. equi merozoite antigen 2 (rEMA-2t). An evaluation of the ability of the BceICT to detect antibodies in sera from uninfected horses and experimentally infected horses showed high sensitivities and specificities of 83.3% (10/12 sera) and 92.9% (52/56 sera), respectively, for the anti-B. caballi antibody and 94.1% (16/17 sera) and 88.2% (45/51 sera), respectively, for the anti-B. equi antibody. Results from the detection of antibodies in field-collected sera indicated that the BceICT results corresponded with those of enzyme-linked immunosorbent assays (ELISA), showing 91.8% correspondence (67/73 sera) for B. caballi and 95.9% correspondence (70/73 sera) for B. equi, and that the BceICT results also corresponded with the ICT for B. caballi and for B. equi, both of which were 98.2% (55/56 sera). The comparable results of the ICT and ELISA and the simplicity and rapidity of the performance of the ICT suggest that the BceICT would be a feasible test for the simultaneous serodiagnosis of both agents of equine babesiosis in the field.
机译:同时开发了一种使用重组B.caballi 48-kDa rhoptry蛋白(rBc48)和重组的截短的B. equi裂殖子裂殖子抗原2(rEMA- 2t)。对BceICT检测未感染马匹和实验感染马匹血清中抗体的能力的评估显示,该抗体的抗敏性和特异性分别为83.3%(10/12血清)和92.9%(52/56血清)。 B. Caballi抗体的抗B抗体分别为94.1%(16/17血清)和88.2%(45/51血清)。等抗体。在现场收集的血清中检测到抗体的结果表明,BceICT结果与酶联免疫吸附测定(ELISA)的结果相对应,显示卡巴氏芽孢杆菌的对应度为91.8%(67/73血清),95.9%的对应度为(70 / 73.血清),BceICT结果也与B. caballi和B. equi的ICT相符,两者均为98.2%(55/56血清)。 ICT和ELISA的可比结果以及ICT性能的简单性和快速性表明,BceICT将是在现场对马马贝贝病的两种药物同时进行血清诊断的可行测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号